1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Vaccine Delivery Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Vaccine Delivery Devices Market Revenue and Volume, by Device Type
8.1.1 Pre-filled Syringes
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Auto-Disable (AD) Syringes
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Safety Syringes & Safety Needles
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Needle-Free Injectors
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Microneedle Patches
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Other Delivery Devices
8.1.6.1. Market Revenue and Volume Forecast
9.1. Vaccine Delivery Devices Market Revenue and Volume, by Technology
9.1.1. Conventional Needle-Based Delivery
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Standard syringes
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Safety engineered syringes
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Needle-Free / Needle-less Delivery
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Jet injectors
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Electroporation / thermal delivery
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Microneedles
9.1.7.1. Market Revenue and Volume Forecast
10.1. Vaccine Delivery Devices Market Revenue and Volume, by End-User
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Public Health / Immunization Programs
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Diagnostic & Specialty Centers
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Homecare / Self-Administration
10.1.4.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Device Type
11.1.2. Market Revenue and Volume Forecast, by Technology
11.1.3. Market Revenue and Volume Forecast, by End-User
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Device Type
11.1.4.2. Market Revenue and Volume Forecast, by Technology
11.1.4.3. Market Revenue and Volume Forecast, by End-User
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Device Type
11.1.5.2. Market Revenue and Volume Forecast, by Technology
11.1.5.3. Market Revenue and Volume Forecast, by End-User
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Device Type
11.2.2. Market Revenue and Volume Forecast, by Technology
11.2.3. Market Revenue and Volume Forecast, by End-User
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Device Type
11.2.4.2. Market Revenue and Volume Forecast, by Technology
11.2.4.3. Market Revenue and Volume Forecast, by End-User
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Device Type
11.2.5.2. Market Revenue and Volume Forecast, by Technology
11.2.5.3. Market Revenue and Volume Forecast, by End-User
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Device Type
11.2.6.2. Market Revenue and Volume Forecast, by Technology
11.2.6.3. Market Revenue and Volume Forecast, by End-User
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Device Type
11.2.7.2. Market Revenue and Volume Forecast, by Technology
11.2.7.3. Market Revenue and Volume Forecast, by End-User
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Device Type
11.3.2. Market Revenue and Volume Forecast, by Technology
11.3.3. Market Revenue and Volume Forecast, by End-User
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Device Type
11.3.4.2. Market Revenue and Volume Forecast, by Technology
11.3.4.3. Market Revenue and Volume Forecast, by End-User
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Device Type
11.3.5.2. Market Revenue and Volume Forecast, by Technology
11.3.5.3. Market Revenue and Volume Forecast, by End-User
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Device Type
11.3.6.2. Market Revenue and Volume Forecast, by Technology
11.3.6.3. Market Revenue and Volume Forecast, by End-User
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Device Type
11.3.7.2. Market Revenue and Volume Forecast, by Technology
11.3.7.3. Market Revenue and Volume Forecast, by End-User
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Device Type
11.4.2. Market Revenue and Volume Forecast, by Technology
11.4.3. Market Revenue and Volume Forecast, by End-User
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Device Type
11.4.4.2. Market Revenue and Volume Forecast, by Technology
11.4.4.3. Market Revenue and Volume Forecast, by End-User
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Device Type
11.4.5.2. Market Revenue and Volume Forecast, by Technology
11.4.5.3. Market Revenue and Volume Forecast, by End-User
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Device Type
11.4.6.2. Market Revenue and Volume Forecast, by Technology
11.4.6.3. Market Revenue and Volume Forecast, by End-User
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Device Type
11.4.7.2. Market Revenue and Volume Forecast, by Technology
11.4.7.3. Market Revenue and Volume Forecast, by End-User
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Device Type
11.5.2. Market Revenue and Volume Forecast, by Technology
11.5.3. Market Revenue and Volume Forecast, by End-User
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Device Type
11.5.4.2. Market Revenue and Volume Forecast, by Technology
11.5.4.3. Market Revenue and Volume Forecast, by End-User
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Device Type
11.5.5.2. Market Revenue and Volume Forecast, by Technology
11.5.5.3. Market Revenue and Volume Forecast, by End-User
12.1. Becton Dickinson & Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. PharmaJet
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Vaxxas
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Gerresheimer AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. SCHOTT AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Corium International, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. 3M
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. SCHOTT AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Nipro Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
